300 filings
Page 4 of 15
8-K
f7obmh
23 Mar 20
Other Events
7:01am
8-K
c4ev0 wzjj8p6b
2 Mar 20
Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates
7:03am
8-K
ykcrm371
12 Feb 20
Other Events
5:20pm
8-K
if6y9t ktvoag
7 Feb 20
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposiumâ„¢ 2020
7:01am
8-K
vaxtgvc
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
b6ma1q42qa7rueie
9 Jan 20
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
7:03am
8-K
9otc2h8nsdzussu 3m
7 Jan 20
Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease
7:01am
8-K
69h9mz
19 Dec 19
Departure of Directors or Certain Officers
4:55pm
8-K
wqdfe2ze0b uz061tqck
14 Nov 19
Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
5:09pm
8-K
ubwv7ktvxhfba8wqa
24 Oct 19
Amicus Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 48th Annual Meeting of the Child Neurology Society
7:00am
8-K
zjzi8mz3x8mo3j1 i6
10 Oct 19
Amicus Therapeutics Announces Preliminary Third Quarter 2019 Revenue and Financial Outlook at 2019 Analyst Day
7:31am
8-K
phwmdxas2oaiskl 8j3
2 Oct 19
Other Events
7:56am
8-K
4oh1dk qamnspa
8 Aug 19
Amicus Therapeutics Announces Second Quarter 2019 Financial Results and Corporate Updates
7:07am
8-K
y8fvddgxb 71sc6td
1 Aug 19
Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
6:10am
8-K
qjs6mtldmjt6qxle4
8 Jul 19
Other Events
4:36pm
8-K
85wh2 obv6oygy5r
2 Jul 19
Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing
7:35am
8-K
tvj41
1 Jul 19
Amicus Therapeutics and Brammer Bio, a part of Thermo Fisher Scientific, Enter Strategic Gene Therapy Development and Manufacturing Collaboration
7:02am
8-K
kadfey5uz003r69yr en
27 Jun 19
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
krcfx ettvndkotqala
19 Jun 19
Entry into a Material Definitive Agreement
7:00am
8-K
4j9hc icdk
31 May 19
Amicus Therapeutics Announces Public Offering of Common Stock
5:17pm